RARA CRAFT DATABASE for FDA Medical Devices
510(k)K173356

FDA DEVICE FACTS

Ingenia Elition S and Ingenia Elition X R5.4

Philips Medical Systems Nederland B.V.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 6, 2018PRODUCT CODELNH

Indications for use

This system is a Magnetic Resonance Medical Electrical Systems indicated for use as a diagnostic device. The system can produce cross-sectional images, spectroscopic images and/or spectra in any orientation of the internal structure of the head, body or extremities.

Magnetic Resonance images represent the spatial distribution of protons or other nuclei with spin. Image appearance is determined by many different physical properties of the tissue and the anatomy, and the MR scan technique applied. The image acquisition process can be synchronized with the patient’s breathing or cardiac cycle. The systems can use combinations of images to produce phy sical parameters, and related derived images.

Images, spectra, and measurements of physical parameters, when interpreted by a trained physician, provide information that may assist the diagnosis and therapy planning. The accuracy of determined physical pa rameters depends on system and scan parameters, and must be controlled and validated by the clinical user. The use of contrast agents for diagnostic imaging applications should be performed consistent with the approved labeling for the contrast agent.

In addition the Philips MR systems provide imaging capabilities, such as MR fluoroscopy, to guide and evaluate interventional and minimally invasive procedures in the head, body and extremities.

MR Interventional procedures, performed inside or adjacent to the Philips MR system, must be performed with MR Conditional or MR Safe instrumentation as selected and evaluated by the clinical user for use with the specific MR system configuration in the hospital. The appropriateness and use of information from a Philips MR system for a specific interventional procedure and specific MR system configuration must be validated by the clinical user. Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging Abbreviated 510(k)

Premarket Notification [510(k)] Submission S5 Philips Medical Systems Nederland B.V. Ingenia Elition S and Ingenia Elition X R5.4

Design Features/ Fundamental Scientific Technology: The proposed Ingenia Elition S and Ingenia Elition X R5.4 are based on t he principle that certain atomic nuclei present in the human body will emit a weak relaxation signal when placed in a strong magnetic field and excited by a radio signal at the precession frequency. The emitted relaxation signals are analyzed by the system and a computed image reconstruction is displayed on a video screen.

The principal technological components (magnet, receive coils and patient support) of the proposed Ingenia Elition S and Ingenia Elition X R5.4 are identical to those used in the legally marketed predicate device, Ingenia 1.5T, Ingenia 1.5T S and Ingenia 3.0T R5.3 (K163116, 01/06/2017), except for the transmit body coil and the gradient coil, which have been changed to adapt to the changed voltage levels of the gradient amplifier.

Based on the information provided above, the proposed Ingenia Elition S and Ingenia Elition X R5.4 does not raise different questions of safety and effectiveness compare d to the legally marketed predicate device Ingenia 1.5T, Ingenia 1.5T S and Ingenia 3.0T R5.3 (K163116, 01/06/2017). Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging Abbreviated 510(k)

Premarket Notification [510(k)] Submission S5 Philips Medical Systems Nederland B.V. Ingenia Elition S and Ingenia Elition X R5.4

Summary of Non- Clinical Performance Data: The proposed Ingenia Elition S and Ingenia Elition X R5.4 comply with the following international and FDA -recognized consensus standards:

 IEC60601-1 Edition 3  IEC60601-1-2 Edition 3  IEC60601-1-6 Edition 3  IEC62366 Edition 1  IEC60601-1-8 Edition 2  IEC60601-2-33 Edition 3  IEC 62304 Edition 1  NEMA MS-1 2008  NEMA MS-4 2010  NEMA MS-8 2008  NEMA PS 3.1-PS 3.20  ISO 14971 Edition 2  Device specific guidance document, entitled “Guidance for the Submission Of Premarket Notifications for Magnetic Resonance Diagnostic Devices – November 18, 2016”  Guidance for Industry and FDA Staff - Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices (issued May 11, 2005)  Guidance for Industry and FDA Staff - Applying Human Factors and Usability Engineering to Medical Devices 9 issued February 3, 2016)  Guidance for Industry and FDA Staff – Content of Premarket Submissions for Management of Cybersecurity in Medical Devices issued October 2, 2014  Guidance for Industry and FDA Staff – Use of International Standard ISO 10993 -1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" (issued June 16, 2016)  Guidance for Industry and FDA Staff – Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically - Powered Medical Devices (issued July 11, 2016)

Non-Clinical verification and or validation tests have been performed with regards to the intended use, the technical claims, the requirement specifications and the risk management results.

The verification and/or validation test results demonstrate that the proposed Ingenia Elition S and Ingenia Elition X R5.4: Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging Abbreviated 510(k)

Premarket Notification [510(k)] Submission S5 Philips Medical Systems Nederland B.V. Ingenia Elition S and Ingenia Elition X R5.4

 Complies with the aforementioned international and FDA recognized consensus standards and Device specific guidance document, entitled “Guidance for the Submission Of Premarket Notifications for Magnetic Resonance Diagnostic Devices – November 18, 2016”  Meets the acceptance criteria and is adequate for its intended use.

Therefore, the proposed Ingenia Elition S and Ingenia Elition X R5.4 are substantially equivalent to the legally marketed predicate device Ingenia 1.5T, Ingenia 1.5T S and Ingenia 3.0T R5.3 (K163116, 01/06/2017) in terms of safety and effectiveness. Summary of Clinical Data: The proposed Ingenia Elition S and Ingenia Elition X R5.4 did not require a clinical study since substantial equivalence to the legally marketed predicate device was proven with the verification/validation testing.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026